The role and mechanisms of the vascular microenvironment in metabolic dysfunction– associated fatty liver disease
4 affiliations
- 1Obesity and Metabolism Medicine-Engineering Integration Laboratory, Department of General Surgery, Affiliated Hospital of Southwest Jiaotong University, The Third People’s Hospital of Chengdu
- 2School of Basic Medical Sciences, Southwest Medical University
- 3Institute of Biomedical Engineering, College of Medicine, Southwest Jiaotong University
- 4Key Laboratory of Advanced Technologies of Materials, Ministry of Education, School of Materials Science and Engineering, Southwest Jiaotong University
Abstract
Metabolic dysfunction–associated fatty liver disease (MAFLD) is the leading cause of chronic liver disease worldwide and is increasingly recognized as a multisystem disorder driven by intertwined metabolic and vascular dysfunction. Beyond the classical features of steatosis, inflammation, and fibrosis, emerging evidence suggests that disruption of the hepatic vascular microenvironment may contribute to MAFLD progression, although its temporal relationship with metabolic injury requires further validation. The liver sinusoid constitutes a highly specialized vascular niche in which liver sinusoidal endothelial cells (LSECs) function as metabolic gatekeepers and mechanosensors, integrating blood flow, shear stress, and nutrient exchange to maintain hepatic homeostasis. In MAFLD, endothelial metabolic reprogramming, reduced nitric oxide bioavailability, and sinusoidal microcirculatory impairment collectively disrupt vascular regulation, thereby promoting lipotoxicity, inflammatory activation, and tissue hypoxia. These processes may be further amplified by multicellular crosstalk, wherein immune cells exacerbate endothelial dysfunction, while hepatic stellate cells (HSCs) promote extracellular matrix deposition, vascular stiffening, and increased sinusoidal resistance. In this review, we synthesize current evidence from a vascular microenvironment perspective and propose a stage-associated conceptual framework encompassing early endothelial stress, immune–endothelial amplification, and fibrotic remodeling. We also discuss emerging therapeutic strategies targeting endothelial metabolism, microcirculatory function, and vascular resistance. By integrating metabolic, inflammatory, and biomechanical processes, this review highlights the hepatic microvasculature as a candidate regulatory hub warranting prospective evaluation as a translational target in MAFLD.
Related
- Metabolic Dysfunction and T-Cell Exhaustion in Colorectal Cancer: Mechanisms, Microenvironment Remodeling, and Therapeutic Opportunities
- Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers.
- Nutritional regulation of the tumor immune microenvironment: metabolic mechanisms, immunotherapy response, and nursing implications
- Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
- Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
BibTeX
@article{li2026role,
title = {{The role and mechanisms of the vascular microenvironment in metabolic dysfunction– associated fatty liver disease}},
author = {Rui Li and Xiaojuan Huang and Shengbiao Li and Tongtong Zhang},
journal = {Frontiers in Endocrinology},
year = {2026},
month = oct,
doi = {10.3389/fendo.2026.1916728},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1916728/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The role and mechanisms of the vascular microenvironment in metabolic dysfunction– associated fatty liver disease
AU - Rui Li
AU - Xiaojuan Huang
AU - Shengbiao Li
AU - Tongtong Zhang
PY - 2026
DA - 2026/10/30
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1916728
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1916728/full
AB - Metabolic dysfunction–associated fatty liver disease (MAFLD) is the leading cause of chronic liver disease worldwide and is increasingly recognized as a multisystem disorder driven by intertwined metabolic and vascular dysfunction. Beyond the classical features of steatosis, inflammation, and fibrosis, emerging evidence suggests that disruption of the hepatic vascular microenvironment may contribute to MAFLD progression, although its temporal relationship with metabolic injury requires further validation. The liver sinusoid constitutes a highly specialized vascular niche in which liver sinusoidal endothelial cells (LSECs) function as metabolic gatekeepers and mechanosensors, integrating blood flow, shear stress, and nutrient exchange to maintain hepatic homeostasis. In MAFLD, endothelial metabolic reprogramming, reduced nitric oxide bioavailability, and sinusoidal microcirculatory impairment collectively disrupt vascular regulation, thereby promoting lipotoxicity, inflammatory activation, and tissue hypoxia. These processes may be further amplified by multicellular crosstalk, wherein immune cells exacerbate endothelial dysfunction, while hepatic stellate cells (HSCs) promote extracellular matrix deposition, vascular stiffening, and increased sinusoidal resistance. In this review, we synthesize current evidence from a vascular microenvironment perspective and propose a stage-associated conceptual framework encompassing early endothelial stress, immune–endothelial amplification, and fibrotic remodeling. We also discuss emerging therapeutic strategies targeting endothelial metabolism, microcirculatory function, and vascular resistance. By integrating metabolic, inflammatory, and biomechanical processes, this review highlights the hepatic microvasculature as a candidate regulatory hub warranting prospective evaluation as a translational target in MAFLD.
SN - 1664-2392
ER -